Literature DB >> 11709325

Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats.

H Ando1, Y Nishio, K Ito, A Nakao, L Wang, Y L Zhao, K Kitaichi, K Takagi, T Hasegawa.   

Abstract

The effects of Klebsiella pneumoniae endotoxin on the biliary excretion and renal handling of rhodamine-123 were investigated in rats at different times after intraperitoneal injection (1 mg/kg of body weight). The typical substrates for P glycoprotein, i.e., cyclosporine, colchicine, and erythromycin, inhibited the biliary clearance of rhodamine-123, whereas a substrate for organic cation transporter, cimetidine, did not inhibit clearance, suggesting that rhodamine-123 is transported mainly by P glycoprotein. The biliary, renal, and tubular secretory clearances of rhodamine-123 and the glomerular filtration rate significantly decreased 6 h after injection of endotoxin but returned to control levels by 24 h. These results suggest that endotoxin-induced decreases in P-glycoprotein-mediated biliary excretion and renal handling of rhodamine-123 were probably due to impairment of P-glycoprotein-mediated transport ability. Pretreatment with pentoxifylline (50 mg/kg) significantly inhibited endotoxin-induced increases in tumor necrosis factor alpha (TNF-alpha) levels in plasma, which ameliorated the endotoxin-induced reduction of the biliary excretion of rhodamine-123. It is likely that endotoxin-induced impairment of the transport of rhodamine-123 is caused, in part, by overproduction of TNF-alpha. The effect of endotoxin on the expression of P-glycoprotein mRNA in liver and kidneys of rats was investigated by using a reverse transcriptase PCR. The expression of Mdr1a mRNA in both liver and kidney decreased 6 h after endotoxin injection and returned to control levels after 24 h, whereas the expression of Mdr1b mRNA in liver increased at both times and that in kidney decreased at 24 h. These findings suggest that K. pneumoniae endotoxin dramatically decreases P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 probably by decreasing the expression of Mdr1a, which is likely due to increased plasma TNF-alpha levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709325      PMCID: PMC90854          DOI: 10.1128/AAC.45.12.3462-3467.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  43 in total

1.  Expression of a multidrug-resistance gene in human tumors and tissues.

Authors:  A T Fojo; K Ueda; D J Slamon; D G Poplack; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

2.  Effect of the p-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain: an in vivo microdialysis study in freely moving rats.

Authors:  Q Wang; H Yang; D W Miller; W F Elmquist
Journal:  Biochem Biophys Res Commun       Date:  1995-06-26       Impact factor: 3.575

3.  The function of Gp170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles.

Authors:  Y Kamimoto; Z Gatmaitan; J Hsu; I M Arias
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

4.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  Decreased antipyrine clearance following endotoxin administration: in vivo evidence of the role of nitric oxide.

Authors:  K Kitaichi; L Wang; K Takagi; M Iwase; E Shibata; M Nadai; T Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

6.  Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo.

Authors:  L Wang; K Kitaichi; C S Hui; K Takagi; K Takagi; M Sakai; K Yokogawa; K I Miyamoto; T Hasegawa
Journal:  Clin Exp Pharmacol Physiol       Date:  2000-08       Impact factor: 2.557

7.  Structure of the polysaccharide moiety of the Klebsiella O3 lipopolysaccharide isolated from culture supernatant of decapsulated mutant (Klebsiella O3:K1-).

Authors:  T Hasegawa; M Ohta; I Nakashima; N Kato; K Morikawa; T Harada; T Okuyama
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-01       Impact factor: 1.645

8.  Inhibitory effect of erythromycin on P-glycoprotein-mediated biliary excretion of doxorubicin in rats.

Authors:  S Kiso; S H Cai; K Kitaichi; N Furui; K Takagi; K Takagi; T Nabeshima; T Hasegawa
Journal:  Anticancer Res       Date:  2000 Sep-Oct       Impact factor: 2.480

9.  Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.

Authors:  T Tsuruo; H Iida; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

10.  Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line.

Authors:  P R Twentyman; N E Fox; D J White
Journal:  Br J Cancer       Date:  1987-07       Impact factor: 7.640

View more
  9 in total

1.  Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin.

Authors:  Masami Sugie; Emiko Asakura; Ying Lan Zhao; Shoko Torita; Masayuki Nadai; Kenji Baba; Kiyoyuki Kitaichi; Kenji Takagi; Kenzo Takagi; Takaaki Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

2.  Shiga-like toxin II derived from Escherichia coli O157:H7 modifies renal handling of levofloxacin in rats.

Authors:  Ying Lan Zhao; Xiao Bo Cen; Masafumi Ito; Keiko Yokoyama; Kenji Takagi; Kiyoyuki Kitaichi; Masayuki Nadai; Michio Ohta; Kenzo Takagi; Takaaki Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

3.  Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin.

Authors:  Kerry B Goralski; Georgy Hartmann; Micheline Piquette-Miller; Kenneth W Renton
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

4.  Effects of hepatic ischemia-reperfusion injury on the P-glycoprotein activity at the liver canalicular membrane and blood-brain barrier determined by in vivo administration of rhodamine 123 in rats.

Authors:  Mohammad K Miah; Imam H Shaik; Ulrich Bickel; Reza Mehvar
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

5.  Inflammatory regulation of ATP binding cassette efflux transporter expression and function in microglia.

Authors:  Christopher J Gibson; Muhammad M Hossain; Jason R Richardson; Lauren M Aleksunes
Journal:  J Pharmacol Exp Ther       Date:  2012-08-31       Impact factor: 4.030

6.  Effect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir.

Authors:  Tomas Laho; John D Clarke; Anika L Dzierlenga; Hui Li; David M Klein; Michael Goedken; Stanislav Micuda; Nathan J Cherrington
Journal:  Biochem Pharmacol       Date:  2016-07-02       Impact factor: 5.858

7.  Characterization of rhodamine-123 as a tracer dye for use in in vitro drug transport assays.

Authors:  Samantha Forster; Alfred E Thumser; Steve R Hood; Nick Plant
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

8.  Spatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in Rats.

Authors:  Kelly M DeMars; Changjun Yang; Kimberly E Hawkins; Austin O McCrea; David M Siwarski; Eduardo Candelario-Jalil
Journal:  J Exp Neurosci       Date:  2017-04-07

9.  Impact of Viral Inflammation on the Expression of Renal Drug Transporters in Pregnant Rats.

Authors:  Navaz Karimian Pour; Eliza R McColl; Micheline Piquette-Miller
Journal:  Pharmaceutics       Date:  2019-11-22       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.